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For more than 25 years cardiologists have sought a method
for the accurate determination of myocardial viability to
evaluate and guide treatment in patients with acute infarc-
tion. Recently this search has been expanded to include
assessment of viability in patients with chronically ischemic
or "hibernating" myocardium that may be present long after
the initial insult has occurred, Although these two situations
share many characteristics, the requirements for an accept-
able technique to define them may be considerably different.
In an acute, evolving infarction the method should be simple
and rapidly acquired, allow monitoring and access to the
patient, have results available within minutes of completion
and permit frequent repetition to allow monitoring of ther-
apy . In chronic ischemia, rime is not as critical . Patients are
usually in stable condition and decisions about treatment
need not be immediate
. Ideally the procedure would also be
applicable to patients with heart failure, in whom it could
help distinguish recoverable forms of myopathy from irre-
versibly damaged muscle.
E eetrocardioseaphle (ECG) estimates of Infarct size . In
the 1970s; the major test to estimate the extent of myocardial
necrosis was the sum of ST segment elevation from multiple
sites (1-4) . The rationale was simple: the higher the ST
segment elevation, the larger the zone of ischemic injury . If
the height of the ST segments was lowered, less myocardium
would become necrotic. The clinical use of nitroglycerin
during acute infarction was primarily based on studies that
measured benefit by alterations in ST segment elevation
(2,4)
. However, it was subsequently recognized that, at best,
this approach was limited in the presence of conduction
abnormalities
. hypertrophy or certain drugs independent of
any effect on ischemia. The theoretic relation between ST
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segment measurements and the size of the igjured region was
critically evaluated by Fozzard and DasGupta (5) with the
conclusion that "inferences from the extent or magnitude of
ST changes overlying an area of ischemia may be misleading
and ST segment mapping should not be used as an indepen-
dent measure of ischemia ."
Binchendal reci iati s of infarct size. Sabel et al . (6) pro-
posed that infarct size could be determined with the use 4:f
myocardial creatine kinase (CK) enzymes by integrating the
area under the curve generated from multiple, frequent
enzyme measurements. Although this approach is suitable
for controlled studies with large numbers of patients, it
provides little information for therapy in the acute stage of
infarction or management of patients with chronic ischemia .
The introduction of thrombolytic agents to the treatment
regimen further complicates the measurement (7) .
Ventricular function
. Regional abnormalities in left ven-
tricular wall motion occur within seconds of the onset of
ischemia
. After reperfusion it may take 7 to 10 days before
viable tissue recovers function (8). Therefore, the presence
of regional dysfunction does not by itself indicate irrevers-
ible disease
. In chronic ischemia the ability to increase left
ventricular ejection fraction after isotropic stimulation pre-
dicts a good prognosis in patients with coronary artery
disease (9) . Similarly, lessening of regional wall motion
abnormalities after nitroglycerin administration also pre-
vides presumptive evidence for viability.
Radlauelide amassment of viabYYy. Radionuclide imag.
ing allows visualization of normal and abnormal myocardium
on the basis of alterations in perfusion, metabolism or
function. Medically useful radionuclides can be separated on
their mode of decay into two groups: single photon or
positron emittors . Single photon emittors (thallium-201,
technetium-99!n) release gamma photons that leave the
tissue in a random direction. Regional activity cannot be
accurately quantitated because of attenuation of activity
from overlying tissue and the effects of scatter from photons
outside the area of interest. Positron tracers (carbon-11,
fluorine-18, nitrogen. 13, rubidium-82) decay by the emission
of a positron, a particle that has the mass of an electron but
a positive rather than a negative charge . After traveling a few
millimeters in tissue, the positron collides with an electron
and releases two high energy photons that go 180° apart .
Tracer activity can be localized and quantified using coinci-
dence detection so that the activity is accepted only when
each of file two paired detectors records the photons .
Thallium-201 perfusiommlistribition studies . Thallium-
201 is a diffusible cation that is taken up by myocardial tissue
in proportion to flow (10). Initial images are therefore an
index of perfusion . Over the next several hours thallium
equilibrates (redistributes) in the myocardium and reflects
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activity in the potassium pool that requires a functioning cell
membrane (11,12). Thus, delayed images that demonstrate
resolution of perfusion defects can be used to assess tissue
viability. In acute myocardial infarction, thallium scans can be
used to document perfusion deficits (13) . However. the redis-
tribution images cannot be performed until decisions about
interventions have been made . Thallium-201 is also con-
strained by a long half-life (73 h) that decreases the allowable
dose and precludes restudy during the acute process.
In hibernating myocardium the filling in of stress-induced
perfusion defects on redistribution (late) images is taken as a
measure of viability. The sensitivity is improved if redistri-
bution images are obtained 24 h later (14) . However . recent
studies (15,16) have shown that between 38% and 58% of
thallium defects that am interpreted as showing scar are
viable as judged by uptake of 2-fluoro-2-deoxyglu .ose (F1)G)
by position emission tomographic (PET) imaging . A recently
presented study (17) suggests that the diagnostic accuracy of
thalliumfordetermiring viability is enhanced by the addition
of a second injection of the tracer if the defect persists on a
4 h redistribution image .
Idarct-inld tracers, Technetium-99m pyrophosphate and
indium-I l
1-labeled
myosin antibody localize regions of myo-
cardial necrosis (18)
. Unfortunately, images obtained with
these tracers do not b :come positive until several hours after
irreversible changes have occurred and the tracers require time
for delivery to the damaged tissue . Sequential scanning with
thallium-201 (perfusion) can be followed by an infarct-avid
tracer (necrosis) so that the difference is related to hypoper-
fused, viable myocardium . Problems with scatter and variable
attenuation, as well as the discrepancy between thallium stud-
ies and FDG, suggest that this approach may be
of limited
value .
Positron emitters. Positron-emitting isotopes include car-
bon-I I, oxygen-15, nitrogen-13 . fluorine-I8 and rubidium-82 .
The first four tracers can be incorporated into virtually any
important physiologic or pharmacologic moiety, thus allow-
ing metabolic imaging. Most studies of myocardial viability
have utilized FDG, a nonmetabolizable analogue of glucose .
The uptake and phosphorylation of FDG requires a viable
cell
. Schelbert and his colleagues (19 .20) have demonstrated
that myocardial viability can be identified by the uptake of
FDG in hypoperfused myocardium . Patients with areas of
glucose uptake are much more likely to recover regional left
ventricular function after revascularization than are patients
without areas of glucose uptake
. FDG is well suited to the
evaluation of patients suspected of having residual viable
myocardium after infarction
. However, it is not practical for
patients with acute infarction because of the time needed to
complete the imaging sequence . The study requires at [east
1 .5 h and includes an attenuation scan (15 to 20 min) .
perfusion image (15 to 20 min) and time for uptake of FDG
(approximately 45 min followed by a II) to 15 min acquisi-
tion) . The synthesis o1 tracer also requires either a fully
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automated cyclotron and chemical synthesis or an in-house
physicist and chemist to avoid further delays
.
Other metabolic tracer, Several other metabolic tracers
have been proposed as indexes of viability including carbon-
II palmitate, carbon-11 acetate and carbon-II pyruvate .
Carbon-I I paimitate is a medium-chained fatty acid analogue
that is taken up by the heart and converted to fatty aryl COA,
which leaves the myocardium only by being oxidized
(21 .22) . The rate of clearance of tracer is therefore related to
the rate of fatty oxidation. However, some carbon-I I palm-
itale leaves the cell before being activated, especially during
ischemia, which readers this measurement less reliable (23)
.
Recovery of normal clearance seems to predict recovery of
regional function in experimental studies. Like FDG, this
approach would only be practica' for the postinfarction
evaluation of viability.
Carbon-1 I acetate is rapidly oxidized by the myocardium
and reflects the state of oxidative metabolism (24). Initial
studies suggest that it too may be useful in assessing viability in
hibernating tissue following infarction . Carbon-I I pyruvate is
taken up and metabolized by aerobic tissue but accumulates as
lactate in areas of ischemia (25). Pyruvate metabolism is
complicates by the potential for multiple routes of conversion
in addition to lactate including transamination .
Rub ldlunr-82- Rubidium-82 is a short-lived (half-life 75 s)
generator-produced diffusible cation that, like thallium and
potassium, is taken up by the myocardium in proportion to
flow (26)
.
Because it is generator produced, tracer can be
made available 24 h a day without the need of any additional
synthetic process
. In experimental studies the tracer remains
in viable tissue for the imaging period but leaks out of
irreversibly injured myocardium presumably because of
damage to the membrane (27,28). The entire imaging se-
quence including an attenuation scan takes <30 min, making
it possible to get information rapidly about myocardial
perfusion )arterial patency) and possibly viability (29). Fur-
ther studies are needed to determine whether this approach
is a reliable indicator of myocardial viability in patients .
Fluorine-18 8aoromlwnidazale. The study by Shelton et
al . (30) in this issue of the Journal presents a novel approach
to the differentiation of hypoxk and normal myocardium
using the positron-emitting tracer fluorine-IS fluoromi-
sonidazole. Extraction of the tracer occurs in hypoperfused
areas early after occlusion but is minimal at 6 or 24 h,
suggesting that the agent may be useful in separating revers-
ible from irreversibly injured necrotic tissue. Unfortunately,
histochemical or pathologic validation, or both, was not
performed to further support the hypothesis .
if fluorine-18 fluoromisonidazole is proved to provide an
accurate way of delineating hypoxic viable myocardium,
how will it be employed clinically? The tracer takes 30 to 45
min to prepare
. Imaging of fluorine-IS fluoromisonidazole in
this study was performed over 45 min and followed the
acquisition of an attenuation scan, blood pool scan and
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perfusion scan
. In the setting of
acute infarction an imaging
procedure that requires up to 2 h from the time the patient is
initially seen for evaluation is too long to be practical. An
additional limitation of this approach is the 108 min half-life
of fluorine-18, which precludes a repeat study for several
hours to monitor the effect
of
treatment. It is more likely that
this approach could be used to determine the presence of
hibernating myocardium in patients with previous infarction,
in whom the issue is whether revascularization of the region
could restore function. Future studies should include com-
parisons with FDG and histologic findings to determine th6
relative merits of the two tracers.
Conclusions. At the present time FDG seems to be the
most accepted indicator of viable, ischemic myocardium . In
the future, imaging with other tracers or magnetic resonance
imaging may supplant it for use in chronic ischemia
. In acute
myocardial infarction there is currently no accurate way of
determining the extent of reversibly injured myocardium
.
The search for a standard continues .
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